Loading company financials…
NEW YORK STOCK EXCHANGE, INC. · Industrial Conglomerates · CIK 0000066740
$175.56
+0.47% · delayed ~15 min
Last price from Oct 22, 2026
$93.10B market value
From 3M CO's FY2025 10-K, filed Feb 3, 2026 · read the filing
3M makes medical devices and equipment. It took in $24.95B last year, which makes it a large company. Of every dollar it sells, about 13 cents is left as profit.
The financial picture is led by profitability and accounting, with growth and debt worth watching.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Financial health
Strong finances across the board.
From 3M CO's FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Free cash flow
$638.0M → $1.40B
Profit
$4.17B → $3.25B
Profit margin
17.0% → 13.0%
Earnings per share
$7.74 → $6.13
Measured against FY2024, from the 10-K filed Feb 3, 2026
Improved: +118.8%
$638.0M to $1.40BCritical
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
How the latest move compares (quote delayed ~15 min), and what was published around it
MMM rose 0.47% on the latest quote. The average Health Care company tracked here moved +1.62%, and the S&P 500 −1.04%. That is 1.1 points below its sector and 1.5 points above the market.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Opinions from 25 analysts covering this company, as of . Their views, not this site's.
Of 25 analysts publishing on this company, 4 say strong buy, 9 say buy, 11 say hold and 1 say sell. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 13 cents of every dollar of sales as profit, earning $3.25B last year.
Barely. Sales were roughly flat, up 1.5%.
Manageable, but notable. Clearing its debt would take about 3.2 years of cash flow. For every $1 it owes, it owns $1.14 in assets.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It pays out 48 cents of every dollar of profit and keeps the rest, which leaves the payment comfortably covered. It paid out 68% of the cash its operations generated. It has paid in each of the last 12 years.
GoodNext payment expected around , projected from how regularly it has paid before rather than from a date the company has announced.
Figures from the FY2025 annual filing
Last year it earned $3.25B and generated $2.31B of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 3, 2026Filing for FY2025 | FY202410-K · Feb 5, 2025Filing for FY2024 | FY202310-K · Feb 5, 2025Filing for FY2023 | FY202210-K · Feb 5, 2025Filing for FY2022 | FY202110-K · Feb 7, 2024Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $24.95B | $24.57B | $24.61B | $26.16B | $35.35B | +1.5% |
| Cost of revenue | $14.99B | $14.45B | $14.98B | $15.85B | $18.80B | +3.8% |
| Gross profit | $9.96B† | $10.13B† | $9.63B† | $10.31B† | $16.56B† | −1.7% |
| Gross marginGross profit ÷ revenueWhat is this? | 39.9% | 41.2% | 39.1% | 39.4% | 46.8% | −1.3 pts |
| Selling, general and administrative | $4.00B | $4.22B | $19.20B | $7.23B | $7.20B | −5.3% |
| Operating income | $4.63B | $4.82B | -$10.69B | $4.37B | $7.37B | −4.0% |
| Operating marginOperating income ÷ revenueWhat is this? | 18.6% | 19.6% | -43.4% | 16.7% | 20.8% | −1.1 pts |
| Interest expense | $448.0M | $472.0M | $942.0M | $462.0M | $488.0M | −5.1% |
| Income before tax | $4.21B | $4.82B | -$11.27B | $4.20B | $7.20B | −12.6% |
| Net income | $3.25B | $4.17B | -$7.00B | $5.78B | $5.92B | −22.1% |
| Net marginNet income ÷ revenueWhat is this? | 13.0% | 17.0% | -28.4% | 22.1% | 16.7% | −4.0 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $6.13 | $7.74 | $-12.66 | $10.52 | $10.35 | −20.8% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| MMM3M CO · this page | 8.0/10 | 5/9 | 1.5% | 13.0% | 28.64x |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Exercised stock options — 1,288 shares at $162.12 ($208.8K)
Holds 8,259 shares after this filing.
Exercised stock options — 219 shares at $162.12 ($35.5K)
Holds 8,478 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Quarterly report for Q3 FY2026
Operating margin +1.5 pts · Profit +64.6% · Profit margin +8.1 pts — against Q3 FY2025
Read the filingPublished results
Read the filingWrite down why you are following 3M CO, what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 39 subsidiaries named in its 10-K, incorporated across 21 places. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from MMM's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Feb 3, 2026), reported under the US GAAP taxonomy. View the source filing.
4 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. All four had enough reported figures. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 9 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 8.0 | 5/9 | 10-K, filed Feb 3, 2026 |
| FY2024 | 7.0 | 7/9 | 10-K, filed Feb 5, 2025 |
| FY2023 | 4.0 | 4/9 | 10-K, filed Feb 7, 2024 |
| FY2022 | 8.0 | 4/9 | 10-K, filed Feb 8, 2023 |
| FY2021 | 9.0 | 7/9 | 10-K, filed Feb 9, 2022 |
| FY2020 | 9.0 | 8/9 | 10-K, filed Feb 4, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
5 of 9 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's.
4.39
In the safe zone
For this model, above 2.99 is safe and below 1.81 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
-2.27
Below the threshold — nothing unusual flagged
Scores above -1.78 are the ones the model associates with earnings manipulation.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Deteriorated: -22.1%
$4.17B to $3.25BSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: −4.0 pts
17.0% to 13.0%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -20.8%
$7.74 to $6.13Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Changed: -21.2%
$1.98B to $1.56BSignificant
Why it matters: Cash handed to shareholders. A rise can be a higher dividend or simply more shares, and a cut is a decision the company explains in its own filing — neither is rated here.
Changed: -22.9%
$1.18B to $910.0MSignificant
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Deteriorated: −1.3 pts
41.2% to 39.9%Notable
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Deteriorated: −1.1 pts
19.6% to 18.6%Notable
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: -6.5%
$5.60B to $5.24BNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: -1.7%
539.5M to 530.3MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q3 FY2026 against Q3 FY2025, from the 10-Q filed Oct 20, 2026 — read it.
Improved: +64.6%
$834.0M to $1.37BCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +8.1 pts
12.8% to 20.9%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: +69.2%
$1.57 to $2.66Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +7.7%
$1.45B to $1.56BNotable
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +1.5 pts
22.2% to 23.7%Notable
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: +5.9%
$11.85B to $12.56BNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Improved: -2.7%
531.2M to 516.7MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q3 FY2026 against Q2 FY2026, from the 10-Q filed Oct 20, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Improved: +58.3%
$984.0M to $1.56BCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +47.2%
$933.0M to $1.37BCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +8.5 pts
15.1% to 23.7%Critical
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +46.9%
$1.81 to $2.66Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +63.6%
$2.96B to $4.83BCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +6.5 pts
14.4% to 20.9%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: +15.2%
$10.90B to $12.56BSignificant
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
4 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 1.8% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 24.5x — investors pay $24.5 for each $1 of trailing profit.
Nothing unusual. Its accounting patterns look like those of companies that report earnings straightforwardly.
| 7.02x |
| HONHONEYWELL INTERNATIONAL INC | 8.0/10 | 5/9 | 7.8% | 12.6% | 29.33x | 4.30x |
|---|
| Median of peers | 8.0/10 | — | 7.8% | 12.6% | 29.33x | 4.30x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Exercised stock options — 217 shares at $162.12 ($35.2K)
Holds 8,695 shares after this filing.
Had shares withheld to cover taxes — 1,724 shares at $162.12 ($279.5K)
Holds 6,971 shares after this filing.
Exercised stock options — 53 shares at $162.12 ($8.6K)
Holds 4,828 shares after this filing.
Had shares withheld to cover taxes — 53 shares at $162.12 ($8.6K)
Holds 4,775 shares after this filing.
Exercised stock options — 176 shares at $162.12 ($28.5K)
Holds 44,028 shares after this filing.
Had shares withheld to cover taxes — 176 shares at $162.12 ($28.5K)
Holds 43,852 shares after this filing.
Exercised stock options — 10,944 shares at $163.02 ($1.8M)
Holds 17,356 shares after this filing.
Had shares withheld to cover taxes — 4,991 shares at $163.02 ($813.6K)
Holds 12,365 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 3,635 shares ($663.4K) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 7,880 shares ($1.3M) on or after .
Shares originally obtained via Stock Option Exercise.
Filed notice to sell 924 shares ($156.5K) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 7,669 shares ($1.3M) on or after .
Shares originally obtained via Stock Option Exercise.
Filed notice to sell 4,902 shares ($835.6K) on or after .
Shares originally obtained via Stock Option Exercise.
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Made a Regulation FD disclosure
Reported another event
Read the filingSigned a material agreement · Terminated a material agreement · Took on a direct financial obligation
Read the filingQuarterly report for Q2 FY2026
Operating margin −2.8 pts · Profit +29.0% · Earnings per share +33.3% — against Q2 FY2025
Read the filingPublished results
Read the filingHad a director or senior officer leave or join
Read the filingHeld a shareholder vote
Read the filingSigned a material agreement · Took on a direct financial obligation
Read the filingQuarterly report for Q1 FY2026
Operating margin +2.2 pts · Profit -41.5% · Free cash flow turned positive — against Q1 FY2025
Read the filingPublished results
Read the filingProxy statement for a shareholder meeting
Read the filingHad a director or senior officer leave or join
Read the filingAnnual report for FY2025
Operating margin −1.1 pts · Free cash flow +118.8% · Profit -22.1% — against FY2024
Read the filingPublished results
Read the filingQuarterly report for Q3 FY2025
Operating margin +1.3 pts · Profit margin −9.0 pts · Profit -39.2% — against Q3 FY2024
Read the filingPublished results
Read the filingHad a director or senior officer leave or join
Read the filingQuarterly report for Q2 FY2025
Operating margin −2.4 pts · Cash -63.2% · Profit -36.9% — against Q2 FY2024
Read the filingSource: Exhibit 21 of the 10-K filed 2026-02-03. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Coverage from the last 30 days
Is 3M (MMM) A Bargain Following Strong Q3 Results And Its AWS Expansion?
Yahoo ·
Will Earnings Beat Change 3M Stock Narrative (MMM)
Yahoo ·
3M (MMM) Stock Ignores Q3 Earnings Power And Margin Reset
Yahoo ·
3M's Amazon Deal Advances Data Center Growth Opportunity, RBC Says
Yahoo ·
3M and AWS collaborate to advance optical connectivity innovation
Yahoo ·
Citigroup Maintains Neutral on 3M, Raises Price Target to $188
Benzinga ·
MMM Q3 Earnings Call Highlights AI Deals and Higher Outlook
Yahoo ·
3M Analysts Boost Their Forecasts Following Strong Q3 Earnings
Benzinga ·
Bernstein Maintains Market Perform on 3M, Raises Price Target to $197
Benzinga ·
MMM Q3 Deep Dive: Data Center Momentum and Productivity Drive Upgraded Outlook
Yahoo ·
Stock Market Today: Defensive Rally Lifts the Dow 1% as Netflix Slips After Hours and Musk Puts a SpaceX-Tesla Merger on the Table
ChartMill ·
Outside Big Tech, Tuesday's Earnings Winners Jumped as Much as 11%
Yahoo ·
Primary sources and further research